Position in GKOS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,409,828
+$54,663,078 QoQ
Shares Held
446,550
+495.4% QoQ
Ownership
0.757%
of shares outstanding
% of Portfolio
1.62%
of 13F equity value
Holder Rank
#32
of 364 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in GKOS Over Time
Shares Held
Position Value (USD)
Derivatives in GKOS
reported options exposure · as of Jun 30, 2025CallValue
$7,746,750
CallShares
75,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC holds $104,584,241 across 2 Medical Devices names. GKOS ranks #1 (59.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GKOS |
GLAUKOS Corp
This page
|
446,550 | $62,409,828 | |
| 2 | ESTA |
Establishment Labs Holdings Inc.
|
491,486 | $42,174,413 |
All Filings in GKOS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,409,828 | 446,550 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $7,746,750 | 75,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $7,746,750 | 75,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $43,421,919 | 441,190 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $14,270,900 | 145,000 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $109,458,299 | 730,014 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $17,992,800 | 120,000 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $80,440,083 | 617,440 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $6,514,000 | 50,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $48,630,843 | 410,907 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||